文献速递肿瘤 PET/CT

基于[18F]FDG PET/CT影像组学特征与IPI构建列线图预测弥漫大B细胞淋巴瘤预后

A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-10-15

本研究回顾性纳入152例弥漫大B细胞淋巴瘤患者(训练组100例、验证组52例),从治疗前PET/CT的总代谢肿瘤体积和代谢 bulk 体积中提取1245个影像组学特征,用LASSO构建影像组学特征标签,并与IPI联合构建混合列线图。结果显示影像组学特征标签和IPI是PFS与OS的独立预测因素,基于TMTV或MBV的混合列线图AUC均显著高于IPI,且校准良好、净获益更高。

要点

  • 影像组学特征标签与IPI均为DLBCL患者PFS和OS的独立预测因素。
  • 基于TMTV或MBV的混合列线图AUC在训练和验证队列中均显著高于IPI(均P<0.05)。
  • 基于MBV的影像组学分析可作为DLBCL预后评估的潜在方法。

核心结论

  • 联合影像组学特征标签与IPI的混合列线图可显著改善DLBCL的生存预测。

研究设计与样本

  • 回顾性纳入152例DLBCL患者,分为训练队列100例和验证队列52例。
  • 从治疗前PET/CT的TMTV和MBV中提取1245个影像组学特征,采用LASSO算法构建影像组学特征标签。
  • 采用Cox回归构建基于不同影像组学特征标签和临床变量的混合列线图,并用时间依赖ROC曲线、Hosmer-Lemeshow检验和决策曲线分析评估。

主要发现

  • 影像组学特征标签和IPI被确定为PFS和OS的独立预测因素,并被选入构建混合列线图。
  • 基于TMTV和基于MBV的混合列线图在训练和验证队列中的AUC均显著高于IPI(均P<0.05),而两者之间无显著差异(P>0.05)。
  • Hosmer-Lemeshow检验显示基于TMTV和基于MBV的混合列线图在训练和验证队列中均校准良好(均P>0.05)。
  • 决策曲线分析表明混合列线图的净获益高于IPI。

关键数值与推荐

  • 基于TMTV和基于MBV的混合列线图AUC均显著高于IPI(均P<0.05)。
  • 基于TMTV与基于MBV的混合列线图之间AUC无显著差异(P>0.05)。
  • Hosmer-Lemeshow检验均P>0.05提示校准良好。

临床怎么用

  • 治疗前[18F]FDG PET/CT影像组学分析可辅助DLBCL预后分层。
  • 基于MBV的影像组学特征标签联合IPI可用于构建预后列线图。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to develop a novel analytic approach based on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) radiomic signature (RS) and International Prognostic Index (IPI) to predict the progression-free survival (PFS) and overall survival (OS) of patients with diffuse large B-cell lymphoma (DLBCL). METHODS: We retrospectively enrolled 152 DLBCL patients and divided them into a training cohort (n = 100) and a validation cohort (n = 52). A total of 1245 radiomic features were extracted from the total metabolic tumor volume (TMTV) and the metabolic bulk volume (MBV) of pre-treatment PET/CT images. The least absolute shrinkage and selection operator (LASSO) algorithm was applied to develop the RS. Cox regression analysis was used to construct hybrid nomograms based on different RS and clinical variables. The performances of hybrid nomograms were evaluated using the time-dependent receiver operator characteristic (ROC) curve and the Hosmer-Lemeshow test. The clinical utilities of prediction nomograms were determined via decision curve analysis. The predictive efficiency of different RS, clinical variables, and hybrid nomograms was compared. RESULTS: The RS and IPI were identified as independent predictors of PFS and OS, and were selected to construct hybrid nomograms. Both TMTV- and MBV-based hybrid nomograms had significantly higher values of area under the curve (AUC) than IPI in training and validation cohorts (all P < 0.05), while no significant difference was found between TMTV- and MBV-based hybrid nomograms (P > 0.05). The Hosmer-Lemeshow test showed that both TMTV- and MBV-based hybrid nomograms calibrated well in the training and validation cohorts (all P > 0.05). Decision curve analysis indicated that hybrid nomograms had higher net benefits than IPI. CONCLUSION: The hybrid nomograms combining RS with IPI could significantly improve survival prediction in DLBCL. Radiomic analysis on MBV may serve as a potential approach for prognosis assessment in DLBCL. TRIAL REGISTRATION: NCT04317313. Registered March 16, 2020. Public site: https://clinicaltrials.gov/ct2/show/NCT04317313.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhang X, Chen L, Jiang H, et al. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021. PMID: 34651227. doi:10.1007/s00259-021-05572-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。